364 related articles for article (PubMed ID: 23171056)
1. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
Jeffrey M
Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
3. Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
Schmitt HP
Med Hypotheses; 2007; 69(3):596-609. PubMed ID: 17337124
[TBL] [Abstract][Full Text] [Related]
4. Membrane pathology and microglial activation of mice expressing membrane anchored or membrane released forms of Aβ and mutated human Alzheimer's precursor protein (APP).
Jeffrey M; McGovern G; Barron R; Baumann F
Neuropathol Appl Neurobiol; 2015 Jun; 41(4):458-70. PubMed ID: 25131655
[TBL] [Abstract][Full Text] [Related]
5. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
6. Animal models for prion-like diseases.
Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
[TBL] [Abstract][Full Text] [Related]
7. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
8. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
Eraña H; Venegas V; Moreno J; Castilla J
Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
[TBL] [Abstract][Full Text] [Related]
9. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
[TBL] [Abstract][Full Text] [Related]
10. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
Soto C; Estrada L; Castilla J
Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
[TBL] [Abstract][Full Text] [Related]
11. Prion and prion-like diseases in animals.
Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM
Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937
[TBL] [Abstract][Full Text] [Related]
12. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
[TBL] [Abstract][Full Text] [Related]
13. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
Jeffrey M; McGovern G; Sisó S; González L
Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
[TBL] [Abstract][Full Text] [Related]
14. Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies.
Jeffrey M; McGovern G; Makarava N; González L; Kim YS; Rohwer RG; Baskakov IV
Neuropathol Appl Neurobiol; 2014 Apr; 40(3):296-310. PubMed ID: 23578208
[TBL] [Abstract][Full Text] [Related]
15. Prion diseases: a riddle wrapped in a mystery inside an enigma.
Liberski PP
Folia Neuropathol; 2008; 46(2):93-116. PubMed ID: 18587704
[TBL] [Abstract][Full Text] [Related]
16. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
[TBL] [Abstract][Full Text] [Related]
18. Prions and protein-folding diseases.
Norrby E
J Intern Med; 2011 Jul; 270(1):1-14. PubMed ID: 21481020
[TBL] [Abstract][Full Text] [Related]
19. Possible role for Ca2+ in the pathophysiology of the prion protein?
Peggion C; Bertoli A; Sorgato MC
Biofactors; 2011; 37(3):241-9. PubMed ID: 21698700
[TBL] [Abstract][Full Text] [Related]
20. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
